Presentation is loading. Please wait.

Presentation is loading. Please wait.

Daniel G. Stover, MD, Rosana Eisenberg, MD, David H. Johnson, MD 

Published byAmice Clark Modified over 5 years ago

Similar presentations

Presentation on theme: "Daniel G. Stover, MD, Rosana Eisenberg, MD, David H. Johnson, MD "— Presentation transcript:

1 Anti-N-Methyl-d-Aspartate Receptor Encephalitis in a Young Woman with a Mature Mediastinal Teratoma 
Daniel G. Stover, MD, Rosana Eisenberg, MD, David H. Johnson, MD  Journal of Thoracic Oncology  Volume 5, Issue 11, Pages (November 2010) DOI: /JTO.0b013e3181eba81d Copyright © 2010 International Association for the Study of Lung Cancer Terms and Conditions

2 FIGURE 1 Imaging of mediastinal tumor. A, Computed tomography scan of the chest with intravenous contrast demonstrated a 3.5 cm × 6.2 cm right anterior mediastinal mass with scattered adipose signal; no adenopathy was present. B, Positron emission tomography scan demonstrated intense fludeoxyglucose uptake within the lateral aspect concerning for malignancy. There was no evidence of fludeoxyglucose avid metastasis. Journal of Thoracic Oncology 2010 5, DOI: ( /JTO.0b013e3181eba81d) Copyright © 2010 International Association for the Study of Lung Cancer Terms and Conditions

3 FIGURE 2 Histologic sections of the resected mature teratoma, located in the right inferior pole of the thymus, depicting different types of tissue. A, Skin including epidermis and dermis with adnexal structures. B, Mature neural tissue resembling cerebral cortex. C, Cartilage and adipose tissue. D, Pancreatic tissue (arrow) and cyst lined by keratinized squamous epithelium and mucinous glandular epithelium (left). E, Cyst lined by small intestinal type mucosa (arrow) and surrounded by smooth muscle. F, Residual thymic tissue. Journal of Thoracic Oncology 2010 5, DOI: ( /JTO.0b013e3181eba81d) Copyright © 2010 International Association for the Study of Lung Cancer Terms and Conditions

Download ppt "Daniel G. Stover, MD, Rosana Eisenberg, MD, David H. Johnson, MD "

Similar presentations

Massive Bronchogenic Cyst Joseph B. Levin, BA, Chi Wan Koo, MD, Jessica S. Donington, MD Journal of Thoracic Oncology Volume 5, Issue 11, Pages 1862-1863.

Massive Bronchogenic Cyst Joseph B. Levin, BA, Chi Wan Koo, MD, Jessica S. Donington, MD Journal of Thoracic Oncology Volume 5, Issue 11, Pages
Kazuma Nagata, MD, Reiko Kaji, MD, Keisuke Tomii, MD 

Kazuma Nagata, MD, Reiko Kaji, MD, Keisuke Tomii, MD 
Malignant Triton Tumor of the Brachial Plexus Invading the Left Thoracic Inlet: A Rare Differential Diagnosis of Pancoast Tumor  Jo Dartnell, BSc, MRCS,

Malignant Triton Tumor of the Brachial Plexus Invading the Left Thoracic Inlet: A Rare Differential Diagnosis of Pancoast Tumor  Jo Dartnell, BSc, MRCS,
Inflammatory Myofibroblastic Tumor of the Left Main Stem Bronchus

Inflammatory Myofibroblastic Tumor of the Left Main Stem Bronchus
Noriyasu Usami, MD, Shingo Iwano, MD, Kohei Yokoi, MD 

Noriyasu Usami, MD, Shingo Iwano, MD, Kohei Yokoi, MD 
FDG PET-CT Aids in the Preoperative Assessment of Patients with Newly Diagnosed Thymic Epithelial Malignancies  Marcelo F.K. Benveniste, MD, Cesar A.

FDG PET-CT Aids in the Preoperative Assessment of Patients with Newly Diagnosed Thymic Epithelial Malignancies  Marcelo F.K. Benveniste, MD, Cesar A.
Malignant Pleural Mesothelioma Harboring Both G719C and S768I Mutations of EGFR Successfully Treated with Afatinib  Nobukazu Agatsuma, MD  Journal of.

Malignant Pleural Mesothelioma Harboring Both G719C and S768I Mutations of EGFR Successfully Treated with Afatinib  Nobukazu Agatsuma, MD  Journal of.
Malignant Pleural Mesothelioma Harboring Both G719C and S768I Mutations of EGFR Successfully Treated with Afatinib  Nobukazu Agatsuma, MD  Journal of.

Malignant Pleural Mesothelioma Harboring Both G719C and S768I Mutations of EGFR Successfully Treated with Afatinib  Nobukazu Agatsuma, MD  Journal of.
Rash in a Patient Treated with Pemetrexed for Relapsed Non-small Cell Lung Cancer  Isabelle Declercq, MD, Yolande Lievens, MD, PhD, Eric Verbeken, MD,

Rash in a Patient Treated with Pemetrexed for Relapsed Non-small Cell Lung Cancer  Isabelle Declercq, MD, Yolande Lievens, MD, PhD, Eric Verbeken, MD,
Adenocarcinoma arising from cervical esophageal gastric inlet patch

Adenocarcinoma arising from cervical esophageal gastric inlet patch
Y-L Chang, MD, C-T Wu, MD, Y-C Lee, MD, PhD 

Y-L Chang, MD, C-T Wu, MD, Y-C Lee, MD, PhD 
Mark F. Berry, MD, Thomas A. Sporn, MD, Joseph O. Moore, MD, Thomas A

Mark F. Berry, MD, Thomas A. Sporn, MD, Joseph O. Moore, MD, Thomas A
Primary Malignant Melanoma of the Esophagus: Long-Term Survival After Radical Resection  Vikas Gupta, MS, Rakesh Kochhar, MD, DM, Saroj Kant Sinha, MD,

Primary Malignant Melanoma of the Esophagus: Long-Term Survival After Radical Resection  Vikas Gupta, MS, Rakesh Kochhar, MD, DM, Saroj Kant Sinha, MD,
Jos A. Stigt, MD, PhD, Richard Vossenkaul, MD, Wouter H

Jos A. Stigt, MD, PhD, Richard Vossenkaul, MD, Wouter H
MET-Mutated NSCLC with Major Response to Crizotinib

MET-Mutated NSCLC with Major Response to Crizotinib
KRAS Mutation Analysis Helps to Differentiate Between Pulmonary Metastasis from Colon Adenocarcinoma In Situ and Primary Lung Adenocarcinoma  Taylor M.

KRAS Mutation Analysis Helps to Differentiate Between Pulmonary Metastasis from Colon Adenocarcinoma In Situ and Primary Lung Adenocarcinoma  Taylor M.
Primary Pulmonary NUT Midline Carcinoma: Clinical, Radiographic, and Pathologic Characterizations  Lynette M. Sholl, MD, Mizuki Nishino, MD, Saraswati.

Primary Pulmonary NUT Midline Carcinoma: Clinical, Radiographic, and Pathologic Characterizations  Lynette M. Sholl, MD, Mizuki Nishino, MD, Saraswati.
Rapid Response of Brain Metastasis to Crizotinib in a Patient with ALK Rearrangement– Positive Non–Small-Cell Lung Cancer  Hiroyasu Kaneda, MD, PhD, Isamu.

Rapid Response of Brain Metastasis to Crizotinib in a Patient with ALK Rearrangement– Positive Non–Small-Cell Lung Cancer  Hiroyasu Kaneda, MD, PhD, Isamu.
Complete Response Achieved 1 Year after a Single Administration of Nivolumab in a Patient with Lung Adenocarcinoma with Negative Expression of PD-L1 

Complete Response Achieved 1 Year after a Single Administration of Nivolumab in a Patient with Lung Adenocarcinoma with Negative Expression of PD-L1 
Muhammad Umair Khawar, MD, Bhaskar Bhardwaj, MD, Himanshu Bhardwaj, MD 

Muhammad Umair Khawar, MD, Bhaskar Bhardwaj, MD, Himanshu Bhardwaj, MD 

Similar presentations

Ads by Google